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International variation in the interpretation of
renal transplant biopsies: Report of the CERTPAP Project1
PETER N. FURNESS and NICHOLAS TAUB, for the Convergence of European Renal Transplant
Pathology Assessment Procedures (CERTPAP) Project
CCTT schemas to the histological grades showed no clear diag-International variation in the interpretation of renal transplant
nostic advantage for either system, but a simple computer-biopsies: Report of the CERTPAP Project.
based inference network, which combined data from 12 histo-Background. The Banff working formulation of renal trans-
logical features, out performed either approach. Within theplant pathology is intended to have international application.
“protocol” biopsies studied, long-term survival correlated bet-There remains a need to develop methods to harmonize the
ter with “acute” than with “chronic” histological features.application of such grading systems between laboratories.
Conclusions. These results do not undermine the value ofBanff grades do not always permit precise management deci-
the Banff classification, but they demonstrate a need for cautionsions to be made. Alternative schemes have been devised for
when translating biopsy results between institutions. It is obvi-the diagnosis of acute rejection, but there have been no inde-
ous that evaluation of biopsies in multicenter trials must bependent tests of the different approaches.
Methods. Sections from 55 renal transplant biopsies were done in one center. In the management of individual patients,
circulated around the laboratories of 22 major transplant units the need to interpret Banff grades in the light of local experi-
for the Convergence of European Renal Transplant Pathology ence and clinical information is stressed.
Assessment Procedures (CERTPAP) Project. Participating pa-
thologists were asked to grade 32 different histological features,
without any clinical information. After each circulation of five The Banff working classification of kidney transplant
cases, feedback was provided to participants. Statistical evi- pathology was developed with two distinct aims: “to guidedence of improvement in interobserver variation was sought.
therapy in transplant patients and to help establish anAt the end of the study, correlations with the original clinico-
objective rejection end point in clinical trials” [1]. Evi-pathological diagnosis were sought.
Results. Interobserver variation was greater than has pre- dence of its success in making progress towards these
viously been reported. For every feature studied, some patholo- goals is provided by its almost universal acceptance in
gists consistently under-grade or over-grade. There was rela- clinical trials and research publications where the inter-tively little evidence of improvement in interobserver variation
pretation of renal transplant biopsies is required.as a result of the feedback system. No single feature permitted
The definitions within the Banff classification mostlya reliable diagnosis of acute rejection. Applying the Banff and
represent discrete points imposed on a natural biological
continuum, such as the severity of tubulitis or interstitial
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most important attributes of any scheme of histologicalland); Dominique Droz (Paris, France); Claire M. Hill (Belfast, N.
Ireland); Bela Iva´nyi (Kossuth, Hungary); Silke Kapper (Mannheim, grading are clinical relevance and reproducibility. Nu-
Germany); Erik N. Larsson (Uppsala, Sweden); Aryvdas Laurinavicius merous publications have confirmed the clinical rele-(Vilius, Lithuania); Niels Marcussen (Aachus, Denmark); Anna Paula
Martins (Lisbon, Portugal); Michael J. Mihatsch (Basel, Switzerland); vance of the Banff classification [2–6]. A smaller number
Lydia Nakopoulou (Athens, Greece); Volker Nickeleit (Basel, Switzer- have tested its reproducibility and have found it to be
land); L-H No¨el (Paris, France); Timo Paavonen (Helsinki, Finland);
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Waldherr (Mannheim, Germany). have worked closely together and who therefore may be
expected to have reached a degree of consensus on howKey words: Banff classification, CERTPAP Project, kidney trans-
the Banff classification should be applied. It can be ar-plantation, pathology, histological grading, morphological grading,
CCTT criteria. gued that this is not a sufficiently rigorous test. If a
scheme is to be used globally, then it should be tested 2001 by the International Society of Nephrology
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Table 1. Clinical information collected on each caseglobally. When we interpret publications from different
countries we need to know whether the Banff grades Age of donor
Age of recipientquoted are directly equivalent to our own experience.
HLA matchingTo develop a more rigorous test experienced renal Cause of renal failure (if known)
transplant pathologists were recruited from 22 major Date of transplantation
Duration of any delayed graft functiontransplant centers, scattered over most of the countries
Immunosuppressive protocolof Europe, for the Convergence of European Renal Trans- Date of biopsy
plant Pathology Assessment Procedures (CERTPAP) Lowest serum creatinine (with date)
Most recent serum creatinine (with date)Project. The participants were asked not to make diagno-
Number of acute rejection episodes, and how they were treatedses, but to undertake pure morphological grading of his- Any other relevant complications
tological features. Clinical information was deliberately
withheld, as we did not wish the results to be influenced
by skills of clinical interpretation.
During an earlier study of the Banff classification, lim- a graft with a stable creatinine, or a biopsy for graft
dysfunction where the problem was subsequently shownited to the United Kingdom, participants had requested
better training in the application of the Banff classifica- to be something other than rejection, and responded to
treatment of that problem).tion than was available merely by reading the literature.
In anticipation that with the design of the present study (2) Chronic rejection. A “protocol” biopsy taken from
a stable graft at any time from six months to two yearsinitial reproducibility was likely to be low, from the onset,
a system was implemented whereby results were fed back after engraftment. These biopsies should have been taken
at least five years ago, to provide a reasonable length ofto participants at intervals, to allow them to compare
their grading of the relevant histological features with follow-up to allow a meaningful correlation with subse-
quent clinical outcome.the average of the entire group. We argued that this would
facilitate “convergence” of grading criteria, and hoped Clinical information was collected as defined in Table 1.
From each biopsy twelve sections were cut, six stainedthat this could provide a mechanism whereby such ongo-
ing training could be offered to larger numbers of renal with hematoxylin and eosin (H&E) and six with periodic
acid Schiff (PAS). Groups of five cases, with one H&Etransplant pathologists.
Although clinical information was withheld from par- and one PAS section per case, were circulated by post
around small groups of participants, to allow each partici-ticipants it was collected in some detail. This allowed us
to test the correlation between each histological feature pant two weeks to view the sections and post them on,
while allowing all participants to view the cases in twoand the diagnosis of acute rejection or the subsequent
rate of decline of graft function. It also permitted a simple months. In some centers the responses were agreed by
a small team of observers, sometimes including nephrol-test of the definitions of acute rejection that are implied
in the Banff classification and in the more recent CCTT ogists, in accordance with usual practice at that centre,
but a single response was requested per institution. Theclassification [9], and it allowed us to test other ways
of integrating the histological grades into a clinically postal circulation of the slides was maintained using re-
minder letters generated by a software package pre-meaningful diagnosis.
viously written for the UK National Renal Pathology Ex-
ternal Quality Assessment Scheme (http://www.le.ac.uk/
METHODS
pa/pnf1/eqa/). The number of sections was deliberately
Cases less than the Banff classification recommends, as it would
not have been possible to cut sufficient replicate sectionsTo make the study as representative as possible of
routine work, the microscope sections were provided by from one biopsy. We recognized the risk that different
participants were viewing significantly different sections,the participants. Cases were selected according to the
following criteria: an assessment of the impact of this effect was made, as
discussed later in this article.(1) Acute rejection. Biopsies taken within six months
of transplantation, where subsequent clinical review Participants were asked to return a response sheet for
each case, giving their grading of 32 different histologicalshowed clearly that the transplant either (a) was defi-
nitely suffering from acute rejection (defined as an in- features as defined in Table 2. This list was developed
by discussion with participants. We included all featurescrease in serum creatinine of at least 15% of baseline in
the week preceding the biopsy, followed by a fall to that have definitions in the Banff 97 [10] or CCTT [9]
classifications, together with a selection of other featureswithin 5% following treatment, or loss of the graft to
rejection, with no other changes to explain the changes of personal interest to participants. More detailed defi-
nitions than those given in Table 2 were provided to allin creatinine), or (b) was definitely not suffering from
acute rejection (this is, either a “protocol” biopsy in participants.
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Table 2. Histological features assessed, with abbreviated definitions
Feature Summary of definition
Tubulitis—grade As in Banff 97 (t)
Tubulitis—extent Number per 10 HPF [9]
Luminal neutrophils Present or absent
Isometric vacuolation Present or absent
Anisometric vacuolation Present or absent
Other forms of acute tubular damage Present or absent
Tubular atrophy As in Banff 97 (ct), but expressed as % affected
Glomeruli: number present Number in one section
Early type of allograft glomerulitis As in Banff 97 (g)
Number of glomeruli completely sclerosed Number in one section
Mesangial matrix increase Number showing “moderate increase” (Banff mm) in one section
Glomeruli with segmental sclerosis Simple count
Chronic allograft glomerulopathy As in Banff 97 (cg)
Interstitial edema % of cortex showing edema
Mononuclear cell interstitial infiltration As in Banff 97 (i), but expressed as % affected
Interstitial fibrosis As in Banff 97 (ci), but expressed as % affected
Large lymphocytes Number per single HPF
Plasma cells Number per single HPF
Eosinophils Number per single HPF
Neutrophils Number per single HPF
Interstitial hemorrhage Present or absent
Infarction Present or absent
Number of arterial cross sections Number in one section
Arteriolar hyaline thickening As Banff 97 (ah)
Endothelial cell activation—arterial Graded 0 to 3
Endothelial cell activation—venous Graded 0 to 3
Neutrophils in peritubular capillaries Present or absent
Intimal arteritis As Banff 97 (v)
Arteriolitis Present or absent
Fibrous intimal thickening As Banff 97 (cv)
Breaks in arterial elastica Present or absent
Inflammatory cells in intima in chronic fibrosis Present or absent
In this way, a total of 55 cases were studied, in 11 Since each participant was identified in the database
by a code number, a printout was produced for eachgroups of 5 cases, over a period of approximately two
years. Participants were asked to contribute sections that participant informing how his/her assessment compared
with the whole group. For example, tubulitis is gradedwere technically adequate by the Banff criteria, but some
centers found this difficult to achieve, and in retrospect on a scale of 0 to 3. The average tubulitis grade offered
by all of the participants for all five cases in the first setsome of the sections were found to be below this stan-
dard, though none were inadequate. Inevitably sections was 1.1. If a participant was in the habit of “over-grading”
tubulitis, that participant’s average score for these fivefrom different centers also had different staining charac-
teristics. These problems were felt to be irrelevant to cases might be 1.6. This discrepancy would immediately
be evident in the personal report. Participants were re-the evaluation of reproducibility, as the material avail-
able was the same for all participants, but they do im- minded at intervals that they should use this feedback
to adjust their criteria for grading in order to move to-pinge on any assessment of diagnostic accuracy, as dis-
cussed below. wards a consensus.
Statistical analysisFeedback to participants
All of the responses were entered into a purpose- Do some pathologists consistently under-grade or over-
grade? The average score for each feature was deter-written database in the co-ordinating center in Leicester.
At the end of each circulation, the average grade for mined for each case. Then for each pathologist’s grading
for each feature for each case, the relevant average waseach histological feature was calculated for each case
and a report was produced for circulation to participants. subtracted from the individual pathologist’s score. This

Fig. 1. Evidence of consistent under- or over-grading by individual pathologists, identified by code numbers (mathematical manipulations are
explained in the text).
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left a negative number if a pathologist under-scored this permutation test [12]. Each permutation consisted of
randomly dividing the 55 slides into groups of 25 andfeature and a positive number if it had been over-scored.
Next, the average of these “corrected to zero” figures was 30 slides, respectively, and calculating the difference in
kappa values between them. The resulting P value forcalculated for each pathologist for each feature, across all
cases, together with 95% confidence intervals. The re- the test was the proportion of these permutations where
the absolute value of the difference in kappa was greatersults were placed in rank order and plotted (Fig. 1).
Random variation was expected, but where any patholo- than the absolute value of the difference in kappa be-
tween the original groups of 25 and 30 slides. First, 1000gist had a 95% confidence limit that did not cross the
zero axis, it represented evidence of systematic under- permutations were used, and then any features approach-
ing statistical significance at the 5% level were retestedor over-scoring in comparison with the group.
Inter-observer variation. The analysis of inter-observer with 10,000 permutations. The two-sided test was used
in all cases.variation in a study of this type is mathematically com-
plex. Cohen’s kappa statistic is commonly employed, but To assess how individual pathologists were changing
their practice over the course of the study, the “correctedthis method was originally designed for ordinal data (for
example, benign or malignant) rather than grades on a to zero” figures described above were taken and divided
into the first 25 and the last 30 cases. The average “score”continuum, and it was originally designed for two observ-
ers rather than 22. To use kappa statistics when consider- for each pathologist for feature was calculated for the
first and plotted to demonstrate graphically whether indi-ing continuous variables, it is necessary to divide the
variables into a number of defined ranges. Where avail- vidual pathologists were using the feedback to “con-
verge” toward the average scoring criteria (Fig. 3).able, the Banff definitions were used to do this on a four-
point scale of 0 to 3 (for example, interstitial fibrosis, Correction for high-power field size. Several of the
histological features depend upon an assessment of thetubular atrophy). Where Banff definitions were not avail-
able [for example, numbers of cells per high-power field frequency of a given event (for example, tubulitis, pres-
ence of a specific cell type) in a given area of the section,(HPF)], we examined the data and set levels that divided
it into four groups of as equal a size as possible. based on the area of the observer’s high power field. As
this area can be expected to differ between microscopes,Most published methods for the calculation of kappa
statistics also rely on a complete data set, which was not participants were all asked to measure the diameter of
their high power field using a stage micrometer. The areaavailable to us because of intermittent failures of the
postal system and loss of slides. To overcome the prob- was calculated from the diameter. For those features
that rely on this measurement, the numbers reported bylem of the intermittently missing ratings, kappa statistics
were calculated using the “one-way” multirater method the pathologists were corrected to a nominal area of 1
mm2 and the above measures of inter-observer variationdescribed by Fleiss [11]. This does not use the informa-
tion that it was the same set of observers who rated each were repeated.
Does seeing different sections influence the results? Inof the slides.
To test whether there had been an improvement in order to allow all the pathologists in this study to examine
the same cases, it was not practical for everyone to exam-interobserver reproducibility as a result of the ongoing
feedback system, two approaches were used. First, the ine exactly the same sections and six sets of slides were
used. These were cut as serial sections, but it is neverthe-kappa statistic was calculated for each major feature
within each of the sets of five cases. This produced a set less possible that differences between the sections could
account for some of the interobserver variation. To testof eleven kappa statistics for each histological feature.
The numbers were plotted and subjected to linear regres- this hypothesis, the results for each histological feature
were arranged into six groups, representing the sixsion to test the probability of the slope being greater
than zero (Fig. 2). groups of pathologists; hence, within one group, the pa-
thologists had actually seen the same sections. We thenThis approach would be expected to reveal changes
in interobserver reproducibility that were not uniform sought evidence of differences between the groups that
could not have arisen by chance, by using the permuta-across the duration of the study, as such changes would
produce a non-linearity of the plot. However, the rela- tion test as described previously in this article [12].
tively small numbers of observations in each group of
Correlation with clinical outcomefive cases led to the production of kappa values with
unacceptably large confidence limits; the majority crossed Acute rejection. Of the 55 cases, 41 represented biop-
sies taken for the investigation of acute graft dysfunctionzero.
To resolve this dilemma, a second approach was used, and 14 were protocol biopsies with long follow-up. Ret-
rospective study of changes in serum creatinine and re-in which observations from the first 25 cases and the last
30 cases were compared. Kappa values for the first and sponse to therapy showed 26 to be cases of acute rejec-
tion, all of these obviously being within the “acutethe second groups of slides were compared using the
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Fig. 2. Kappa values calculated for sequential groups of cases. Improving inter-observer agreement should be manifest as a line sloping upward
to the right, but was statistically significant only for interstitial fibrosis (P  0.05).
Fig. 3. Inter-observer variation as assessed in the first half versus the last half of the study. Improved agreement with the consensus of the group
would be evident by a line that moves closer to zero from left to right. For most parameters it appears that some participants converge, but others
do not adjust their criteria.
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Table 3. Reproducibility of assessment of the histological featuresdysfunction” group. The scores for each histological fea-
ture were tested for association with this diagnosis by Feature Kappa
Mann-Whitney U test, using the MiniTab statistics pro- Tubulitis—Banff grade 0.17
Tubulitis per 10 HPF 0.16gram.
Luminal neutrophils 0.33Testing for acute rejection. Various manipulations of Isometric vacuolation 0.19
Anisometric vacuolation 0.12the data were performed to assess the accuracy of differ-
Other forms of acute tubular damage 0.14ent approaches to making a diagnosis of acute rejection,
Tubular atrophy 0.29
in the absence of any clinical data. Each pathologist’s Glomeruli: number present 0.53
Early type of allograft glomerulitis 0.21response to each of the 41 “acute” cases was analyzed to
Number of glomeruli completely sclerosed 0.47test whether the grades given would result in a diagnosis Mesangial matrix increase 0.12
Glomeruli with segmental sclerosis 0.13of acute rejection:
Chronic allograft glomerulopathy 0.11
Interstitial edema 0.17
Mononuclear cell interstitial infiltration 0.341. If Banff “suspicious” [10] or above was taken as
Interstitial fibrosis 0.30indicating acute rejection;
Large lymphocytes 0.13
2. If Banff “acute rejection type 1a” or above was Plasma cells 0.13
Eosinophils 0.17required before diagnosis acute rejection;
Neutrophils 0.05
3. Using the CCTT criteria [9]. Interstitial hemorrhage 0.32
Infarction 0.12
Number of arterial cross sections 0.19
It is arguable that the average score of such a large Arteriolar hyaline thickening 0.11
Endothelial cell activation—arterial 0.21number of pathologists represents the best possible esti-
Endothelial cell activation—venous 0.10mate of the severity of a histological feature within a Neutrophils in peritubular capillaries 0.13
given biopsy. The diagnostic value of these “consensus Intimal arteritis 0.35
Arteriolitis 0.24scores” was tested in the same way.
Fibrous intimal thickening 0.36
We have previously demonstrated the value of using Breaks in arterial elastica 0.22
Inflammatory cells in intima in chronic fibrosis 0.34computer-based expert support systems in integrating
Kappa  1 indicates perfect agreement; kappa  0 indicates completelycomplex data sets to make a diagnosis of acute rejection
random results.[13, 14]. Hence, we designed an inference network using
the commercially available “Netica” software package
(Norsys Corporation) incorporating the 12 histological
features with the highest P values when tested for associ- groups were sought by Mann-Whitney U test, as de-
ation with acute rejection. The network was trained by scribed previously in this article for acute rejection.
entering the probability of acute rejection associated
with each grade of these 12 variables, obtained using the RESULTS
data from all the “acute dysfunction” cases. It was then
Do pathologists consistently under-gradetested for its accuracy in diagnosing acute rejection using
or over-grade?the same cases. We recognized that testing such a net-
Similar results were found for every histological fea-work with cases that have been used in its training is
ture, apart from those that were so infrequent as toless than ideal, but the limited number of cases available
preclude analysis (for example, necrosis, interstitial hem-within this study precluded a more thorough test.
orrhage). A selection of representative graphs of the moreChronic decline in function. Data were used only from
important histological features is shown in Figure 1. Ex-the 14 protocol biopsies, taken during stable graft func-
amination of the error bars (representing 95% confi-
tion. These biopsies were all taken from 5 to 10 years ago; dence limits) demonstrates that for every feature, some
thus, the decline in graft function was assessed simply by pathologists consistently over-grade and some under-
taking the most recent available creatinine level, sub- grade. Examination of the participant codes (along the
tracting from this the creatinine level at the time of horizontal axis) shows a different sequence of codes for
biopsy, and dividing the result by the time between the each case, with no discernable pattern; hence, a patholo-
two measurements. This resulted in a split between six gist who consistently over-grades one feature does not
“stable” grafts (creatinine improved, unchanged or in- seem to be more likely to over-grade another.
creased by less than 50 mol/L over the period of follow-
Inter-observer variationup) and eight “declining” grafts (graft failure or creati-
nine increased by more than 150 mol/L over the period Measurement of inter-observer variation is difficult
and contentious, as discussed above. The usual practiceof follow-up). Significant differences between these
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of defining ranges of kappa values as “good,” “accept- Even without these measurements the variation was very
large (Fig. 4).able,” and “poor” reproducibility ignores the fact that
Correcting the relevant observations for the area ofwhen a continuous variable is split into many grades (for
the high power field of the observer produced no im-example, tubulitis) the “agreement” between observers
provement in the inter-observer variation. Such “cor-is inevitably less likely than if the same feature was
rected” data were not used further in the analysis.merely recorded as “present” or “absent.” Furthermore,
the kappa value is likely to be estimated very inaccu-
Does seeing different sections influence the results?rately for those features that were present very infre-
For the histological features listed in Table 5, therequently (for example, intimal arteritis). Subject to these
was evidence of significant differences between the re-problems in interpretation, the overall kappa statistics
sponses of pathologists who saw different sections fromfor each feature are shown in Table 3. We did not for-
the same biopsy. For all other histological features, nomally test whether reproducibility varied significantly
differences were detectable, suggesting that the compro-between biopsies of different type (for example, acute
mise of using a set of serial sections rather than everyonerejection versus not acute rejection). However, from vi-
viewing the same sections had not introduced spurioussual examination of the data it was clear that for several
inter-observer variation.variables (notably interstitial fibrosis), agreement was
much better when the abnormality was absent. When- Correlation with clinical outcome
ever it was present, agreement on the severity was poor.
Acute rejection. The features that correlated with aThere was only limited evidence of improvement in
subsequent clinical diagnosis of acute rejection are listedinter-observer variation over the course of this study.
in Table 6. Despite the highly significant differences be-When the kappa statistics for each group of five cases
tween the groups, plots of the mean values for eachwere calculated and plotted, the slope of the resultant
case show considerable overlap with every histologicalregression line was upward (indicating improving agree-
feature (Fig. 5). The values plotted are not individualment) for most variables, but with the exception of inter-
opinions; they are the average scores from the valuesstitial fibrosis (P  0.003) this slope was never signifi-
given by all the pathologists in the study. Therefore, itcantly greater than zero at the 5% level of significance
can be argued that they represent the best available(Fig. 2). Analysis the first 25 and last 30 cases also failed
estimate of the score of each feature in each availableto show convincing improvements in reproducibility (Ta-
biopsy. The overlap confirms that no one histologicalble 4).
feature is sufficient to make a reliable diagnosis of acuteA possible explanation for this disappointing result
rejection in isolation.
was evident when individual variation from the mean
Testing for acute rejection. The Banff or CCTT criteria
was plotted for the first 25 and last 30 cases (Fig. 3). were applied to the histological grades given for all the
Visual inspection of these graphs suggests that there are biopsies. The results were compared with the retrospec-
many lines which converge towards the zero axis from tive clinical diagnosis (acute rejection or not acute rejec-
left to right, suggesting that these pathologists have tion) as defined during the case selection process. The
achieved “convergence” toward the average criteria for numbers of correct diagnoses produced are shown in
the group, indeed, a few “overshoot.” This effect is per- Table 7. This approach is not relevant to the accuracy
haps most prominent for tubulitis. However, there are of diagnosis in routine practice, because of the limited
also many participants where the line is remarkably hori- material available and the absence of any clinical infor-
zontal, indicating that the feedback provided has had no mation. It was used to make a comparison between they
impact on that pathologist’s systematic over-grading or way in which two classification systems are used to pro-
under-grading. duce a diagnosis, and we argue that this comparison is
It must also be accepted that, due to the limited amount valid because exactly the same limitations apply to both.
of tissue available, we did not include sections stained Not surprisingly, if Banff “suspicious” is accepted as indi-
to highlight connective tissue or elastin and this may have cating acute rejection, there is over-diagnosis of acute
contributed to the variation seen in some histological rejection, whereas if Banff “suspicious” is excluded, acute
features. rejection is under-diagnosed. The CCTT criteria produce
results that are intermediate between these two, but do
Correction for high-power field size not give an increase in the total number of correct diag-
The existence of a large variation in the area of the noses.
“high-power field” was confirmed. Two extreme mea- The computer-based inference network, which uses a
surements were eliminated as measurement errors and much larger number of relevant histological features
one pathologist could not give a figure as he had used than either of the published schemas, produced correct
diagnoses in 87% of the cases, using morphological dataseveral different microscopes in the course of the study.
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Table 4. Evidence of decreased inter-observer variation over the course of the study
P value
Feature Analysis in 11 groups of 5 cases Analysis of first 25 vs. last 30 cases
Tubulitis—Banff grade 0.337 0.614
Tubulitis per 10 HPF 0.653 0.850
Luminal neutrophils 0.322 0.550
Isometric vacuolation 0.466 0.168
Anisometric vacuolation 0.519 0.812
Other forms of acute tubular damage 0.162 0.021
Tubular atrophy 0.576 0.866 (Decreased)
Glomeruli: number present 0.017 0.115
Early type of allograft glomerulitis 0.284 (Decreased) 0.356 (Decreased)
Number of glomeruli completely sclerosed 0.505 0.114
Mesangial matrix increase 0.147 0.602
Glomeruli with segmental sclerosis 0.221 0.472
Chronic allograft glomerulopathy 0.143 0.358
Interstitial edema 0.852 (Decreased) 0.134 (Decreased)
Mononuclear cell interstitial infiltration 0.818 0.166 (Decreased)
Interstitial fibrosis 0.05 0.030
Large lymphocytes 0.116 0.352
Plasma cells 0.274 (Decreased) 0.667 (Decreased)
Eosinophils 0.595 0.608
Neutrophils 0.031 0.225
Interstitial hemorrhage 0.635 0.540
Infarction 0.582 0.046
Number of arterial cross sections 0.276 0.228
Arteriolar hyaline thickening 0.533 0.618
Endothelial cell activation—arterial 0.864 (Decreased) 0.754
Endothelial cell activation—venous 0.774 (Decreased) 0.806 (Decreased)
Neutrophils in peritubular capillaries 0.006 0.031
Intimal arteritis 0.989 (Decreased) 0.844 (Decreased)
Arteriolitis 0.637 0.836
Fibrous intimal thickening 0.167 0.164
Breaks in arterial elastica 0.637 0.268
Inflammatory cells in intima in chronic fibrosis 0.537 0.816
“Decreased” indicates that the inter-observer agreement appeared to decrease slightly, though in no case was this statistically significant.
Fig. 4. Variation in the size of participants’
“high-power field.”
only. However, it must again be stressed that testing a
network with the cases that have been used to train it
Table 5. Histological features showing evidence of differences may overestimate its performance.
between different sets of serial sections
Chronic decline in function. The features in the 14
Histological feature P value protocol biopsies that correlated with a more rapid de-
Sclerosed glomeruli 0.003 cline in renal function are listed in Table 8. It is notable
Number of glomeruli 0.006 that the most significant features are not those showingNeutrophils in tubules 0.028
Elastic breaks 0.032 histological evidence of chronic damage, such as intersti-
Activated lymphocytes/HPF 0.032 tial fibrosis or tubular atrophy, but are features that are
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Table 6. Histological features which, when found in a biopsy taken There are three explanations for this apparent discrep-
to investigate acute graft dysfunction, showed a positive association
ancy.with a retrospective clinical diagnosis of acute rejection
The first is the very severe and artificial limitations
Histological feature P value under which the pathologists were working. All clinical
Mononuclear cell infiltration 0.0008 information was withheld. To provide enough sections
Tubulitis (Banff grade) 0.0015
from small needle biopsies each pathologist was pro-Tubulitis (count) 0.003
Interstitial edema 0.0036 vided with only two sections per case. Stains to highlight
Intimal arteritis 0.012 elastin and connective tissue were not included. As noted
Large mononuclear cells 0.0013
previously in this article, some sections did not fulfill theAcute glomerulitis 0.027
Venous endothelial changes 0.047 Banff definition of technical adequacy and interinstitu-
tional differences in processing and staining caused prob-
lems for some pathologists. The accurate clinical diagno-
sis or exclusion of acute rejection may be difficult, even
in retrospect, and may have been inaccurate in some cases.normally considered to be evidence of acute damage.
These problems do not detract from a study of reproduc-“Chronic” features such as interstitial fibrosis, tubular
ibility—indeed, with smaller samples one might expectatrophy, intimal fibrosis, and chronic transplant glomeru-
less scope for disagreement—but they do make it muchlopathy did not reach statistical significance, although it
more difficult to arrive at a correct clinical diagnosis.must be admitted that in this part of the study the sample
The second explanation is that pathologists do not, insize is relatively small.
practice, base diagnoses of acute rejection solely on the
degree of tubulitis, interstitial mononuclear cell infiltra-
DISCUSSION tion, and intimal arteritis. Whether consciously or not,
the pattern recognition skills of an experienced histopa-This study has revealed large interobserver variation
thologist will include consideration of other features,in the assessment of renal transplant biopsies, consider-
such as the extent and nature of the infiltrate, the pres-ably larger than has been reported previously [7, 8]. To
ence of edema, and the extent as well as the severity ofsome extent, this is not surprising when the design of the
the tubulitis. We have demonstrated, informally in thisstudy is considered. The participants had never worked
study and more rigorously elsewhere [13, 14] that com-together before. They had mostly trained in different
puter-based decision support systems can integrate suchcountries, under different regimes, and before this study
complex datasets and come to a much more reliable diag-there had been no way other than verbal descriptions
nosis of acute rejection than can be achieved by consider-and published photographs to compare diagnostic crite-
ing only the Banff grades for tubulitis, mononuclear in-ria with pathologists elsewhere in the world.
filtration and intimal arteritis. Such computer-based dataSchemes for histological grading such as the Banff
integration presumably mimics more closely the pro-classification are intended to have worldwide applica-
cesses in the brain of an experienced pathologist. Thetion, so it can be argued that the measurement of inter-
Banff classification’s approach to acute rejection is prin-observer variation in this study is considerably more
cipally directed toward grading acute rejection, and in
relevant to the “real world” than studies involving small
this it has been shown to be successful [2–6]. In excluding
groups of colleagues. It is therefore appropriate to take all but a small subset of the histological features it is
the two stated aims of the Banff classification, and con- not designed to provide ideal diagnostic precision for
sider the implications of these results for each. individual patient care.
The third point is that individual management deci-Implications for management of individual patients
sions are not made in the absence of clinical information.
The first stated aim of the Banff classification is “to In the first description of the Banff classification, it was
guide therapy in transplant patients” [1]. Looking at the stressed that decisions of clinical management should be
data presented here one might be tempted to wonder made in the light of the clinical setting, and “individual
why transplant biopsies are considered to be useful in centers will develop their own strategies for dealing with
the management of individual patients. The proportions various biopsy findings.” It is likely that in some centers
of correct diagnoses in Table 7 are alarmingly low, and a finding of mild tubulitis will usually trigger treatment
there is no clear advantage between the Banff and CCTT of acute rejection, whereas in others mild tubulitis will
approaches. Yet biopsies are widely believed to be useful usually be ignored. This study demonstrates that such
in the diagnosis of acute graft dysfunction. Our results differences may reflect differences between pathologists
appear irreconcilable with previous reports of excellent rather than between patient populations. Hence, as long
concordance in the histological diagnosis of acute rejec- as close liaison between the clinical team and the pathol-
ogist permits ongoing feedback about the accuracy oftion, which are reported to be as high as 97.7% [15].
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Fig. 5. Distribution of average grades for his-
tological features associated with acute rejec-
tion. No single feature permits reliable dis-
crimination.
diagnoses, such variations in histological grading need lymphocytic infiltration, rather than “chronic” features.
The number of protocol biopsies in this study is small,not be reflected in differences in patient management.
In addition to the diagnosis of acute rejection, it would but the result provides support for the importance of
“subclinical acute rejection” in protocol biopsies as anbe of great value if one could predict graft survival at an
important prognostic feature.early stage of engraftment. Most biopsy-based studies that
have addressed this problem have considered histologi-
Implications for clinical trials and interpretation ofcal evidence of chronic damage such as interstitial fibrosis
published studiesand tubular atrophy [16–20]. More recently, there has
been emphasis on the concept of “subclinical acute rejec- The second aim of the Banff classification was “to help
establish an objective rejection end point in clinical trials”tion” as a cause of chronic graft failure—one that is poten-
tially reversible [21]. The present study shows a striking [1]. Here interinstitutional variation in grading can be a
major problem. Our results confirm that when biopsycorrelation between “acute” features such as tubulitis and
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Table 7. Performance of published schemas in identifying cases of acute rejection from morphological data only,
applying cut-off for diagnosis at two different points in the Banff schema
Correct diagnoses using pathologists’ individual responses
Cases of acute rejection (417 responses) Cases not acute rejection (519 responses)
Banff Banff “acute Banff Banff “acute
“suspicious” rejection 1a” CCTT “suspicious” rejection 1a” CCTT
307 (74%) 192 (47%) 253 (61%) 269 (52%) 407 (79%) 305 (59%)
Correct diagnoses using average grades given by the whole group
Cases of acute rejection (26 cases) Cases not acute rejection (29 cases)
Banff Banff “acute Banff Banff “acute
“suspicious” rejection 1a” CCTT “suspicious” rejection 1a” CCTT
21 (81%) 12 (46%) 20 (77%) 13 (45%) 23 (79%) 14 (48%)
Table 8. Histological features which, when found in a protocol require considerable care if the biopsies are reported by
biopsy, showed a positive correlation with a subsequent
different pathologists. They also explain the anecdotalmore rapid decline in renal function
observation of transplant units that when a new patholo-
Histological feature P value gist is appointed, a period of “settling in” is required
Edema 0.006 before mutual trust is established.
Tubulitis grade 0.006
Eosinophil infiltration 0.013
Implications for the future interpretation ofTubulitis per 10 HPF 0.023
Mononuclear cell infiltration 0.061 transplant biopsies
Within one institution, the large variation reported in
this study may have no impact at all on routine care. If
the pathologist reports changes consistently and if theseassessments are part of a clinical trial, these assessments
changes are interpreted in the light of local experience,must be carried out in a single center, preferably by a
then correct clinical decisions will be made even if thesingle pathologist. One cannot rely on results generated
pathologist’s grading is away from any international con-from histological grading if the grading is done in the
sensus. “Borderline” may always mean acute rejectionvarious laboratories associated with a multicenter trial,
in one institution and never in another. If all concernedas any useful signal is likely to be lost in the “noise” of
are aware of this, patient care will not necessarily suffer.interinstitutional variation.
Despite this caveat, a reduction in interinstitutionalOur results also show that great caution must be exer-
variation is obviously desirable for many reasons. In thecised when comparing biopsy results between institu-
short term, this must take the form of improving ourtions. We have never really known why some institutions
existing approaches. In the long term, perhaps we shouldreport levels of acute rejection, even in protocol biopsies,
look harder for alternatives to conventional histologicalwhich are much higher than others, despite apparently
assessment of transplant biopsies.similar immunosuppressive regimens [22]. There is evi-
To improve our existing approach there are two op-dence that some of this variation is genuine, particularly
tions: improved training and improved criteria.where the patient population has different ethnic origins
International co-ordination of training will be difficult,[23], but it seems very likely that part of this variation
but perhaps not impossible. International travel to train-can be explained by variation in grading criteria between
ing sessions might improve consistency, but this is toodifferent pathologists.
expensive for most laboratories, and which laboratoryThis does not mean that published histological grades
should offer the definition of what is correct? It is un-are meaningless. For example, it has recently been con-
likely that any one laboratory could offer the resourcesfirmed that within an episode of acute rejection, the
to train all of the transplant pathologists in the world.grade of tubulitis correlates with the prognosis [5]. A
For this reason we had hoped that the slide circulationcorrelation between more severe types of rejection and
and feedback system developed for this study could bea poor prognosis has been reported by several groups
extended to other laboratories, following the pattern of[3, 4, 6, 24]. Such conclusions can be expected to remain
histopathology external quality assessment schemes intrue in other institutions, even if a biopsy that is called
the United Kingdom [25, 26]. Unfortunately, the level“Suspicious” in one institution is called “type 1b acute
of convergence we have produced does not justify thisrejection” in another. Nevertheless, our results do mean
that comparisons of biopsy findings between institutions approach. Participants in this study offered several expla-
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nations, including “information overload” as a result of
using 32 histological features. The results in Figure 3
also suggest that some pathologists were reluctant to
adjust their long-held opinions as to “correct” practice,
even when shown to be in a minority. We are currently
evaluating a slide circulation scheme that is limited to a
smaller number of “critical” variables, and a scheme that
involves the circulation of images rather than slides.
Improved definitions also are likely to help. Ongoing
development of the Banff definitions has always been
envisaged, and some major improvements were intro-
duced in 1997 [10]. However, there are still ambiguities.
Several of the definitions rely on an assessment of the
“area affected.” This is easy when a change is present
or absent, but much harder (as with most biological pro-
cesses) when the alteration develops gradually (Fig. 6).
Discussion of such questions will be a feature of forth-
coming Banff conferences. It is clear from our results
that any definition based on the size of a microscope’s
high power field should be avoided.
There will, however, be a limit to the reproducibility
of grading by histopathologists. The long-term solution
is likely to involve replacement of such subjective grad-
ing by more objective measurements. There have already
been reasonably successful attempts to diagnose rejec-
tion by measurement of gene expression [27, 28]. Several
groups have shown that chronic damage can be measured
more reproducibly using computerized image analysis
[16–20]. However, these methods have been subjected
to very little clinical evaluation when compared with
years of experience of conventional biopsy assessment.
New methods will carry their own, as yet unmeasured,
interinstitutional variation. Implementation in routine
practice will require prolonged, detailed, multicenter val-
uation. If the “gold standard” of the biopsy is somewhat
tarnished, against what can the new methods be evalu-
ated? This will require close collaboration between clini-
cians, histopathologists and molecular biologists. It may
be difficult to obtain resources to support such work.
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Fig. 6. The problem of assessing area affected by aprogressive process.
(A) 1-bit digital image of renal interstitium (Sirius red staining through
crossed polaroids, digital negative). (B-E) digital manipulations of (A).
If involvement is heavy and patchy (B) assessment of ‘area affected’
may be reliable, but if there is diffuse gradual expansion (C-E) how
can one decide consistently when 0% involvement suddenly becomes
100% involvement?
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